Lab-grown meat is commercially available in major US grocery retail chains before 2028.

Question

Six frontier AI models put this at 12% by 11 Nov 2029. Full reasoning from every model.

WillHappen.ai · Accepted Answer

12% — the median of 6 frontier models, resolving by 2029-11-11.

Answer

Gemini (Google): 12% — Bioreactor scaling bottlenecks and state bans make supermarket-level volume impossible by late 2027. UPSIDE Foods and GOOD Meat still produce kilograms, not thousands of tons needed for national grocery distribution networks. Florida and Alabama have already enacted outright retail bans, chilling major supermarket chains from listing products. A commercial facility breaking ground by early 2027 with cost parity on blended ground meat would push my estimate toward 35.

Answer

Claude (Anthropic): 11% — Scale-up and cost parity for cultivated meat, not regulatory approval, is the binding constraint before 2029. USDA/FDA cleared Upside Foods and Good Meat for restaurant sale in 2023, but retail requires far higher volume at competitive cost. Current cultivated meat production costs remain orders of magnitude above conventional meat, and bioreactor scale-up has repeatedly lagged projections industry-wide. Several state bans (Florida, Alabama, others) and political headwinds add friction even if a producer reaches viable scale by 2028-29.

Answer

GPT (OpenAI): 38% — This turns on whether a producer can reach grocery-grade scale and price after USDA approval, not merely win another tasting-room launch. USDA approved UPSIDE and GOOD Meat chicken in 2023, but neither established broad supermarket distribution by late 2026. A major chain needs reliable inspected supply, labeling clearance, cold-chain logistics, and a price consumers will accept before 2028. Odds rise sharply if UPSIDE, GOOD Meat, or a well-funded rival announces recurring regional chain listings with a commissioned large plant in 2027.

Answer

Grok (xAI): 12% — Whether any producer can ship grocery-scale, priced cultivated meat by late 2027. USDA/FDA already cleared chicken for Upside and GOOD Meat, yet existing plants still yield only restaurant volumes. No cultivated SKU has reached US grocery; plant-based analogs needed 2–4 years after restaurant launch to hit Kroger/Walmart. A signed 2027 retail contract plus a >10-ton/month facility coming online would most raise the odds.

Answer

DeepSeek (DeepSeek): 8% — This turns on whether any cultivated meat producer can reach cost parity and volume for grocery distribution by 2028. UPSIDE Foods and GOOD Meat cleared FDA/USDA in June 2023, but only for restaurant service, not retail shelves. No US facility currently produces at commercial scale; cost per pound remains roughly 10-100x conventional beef. The 2028 window is tight: even if a startup scales, grocery chains need consistent supply and price parity to stock it.

Answer

Qwen (Alibaba): 9% — Cost per pound must drop ~10x and bioreactor scale must jump orders of magnitude in ~14 months. No cultivated meat product has secured shelf space at Kroger, Walmart, Albertsons, or similar; even Whole Foods hasn't carried one as of late 2026. UPSIDE Foods and GOOD Meat still produce at pilot scale with costs estimated at $20+/lb vs. $3-5/lb for conventional chicken—retail buyers won't stock that gap. A surprise partnership (e.g., Tyson subsidizing a limited SKU at Kroger) is the one scenario that could push this above 15%, but no such deal has been announced.

Lab-grown meat is commercially available in major US grocery retail chains before 2028.

The USDA finalizes mandatory labeling rules specifically designating cultivated meat before 2028.

The UN Integrated Food Security Phase Classification declares Phase 5 Famine in at least one country during 2027.

Australia's consumer price index for food and non-alcoholic beverages records annual inflation above 5% in 2027.

The FAO Food Price Index drops below its pre-2021 annual average before 2028.